Drawing for NEON DX

USPTO serial 88202217

NEON DX

Reviewed by CopyMark Law Group

Reg. 6649085Status 700Registered
Filing date
Status date
Registration date
Feb 22, 2022
Examiner
LAVOIE, RYAN CHRISTOPHER
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NEON DX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brooks R. Bruneau

Brooks R. Bruneau FISHERBROYLES, LLP100 OVERLOOK CENTERSECOND FLOORPRINCETON, NJ 08540

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of metabolic disorders, liver diseases, cholestatic diseases, cancers, disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system, inflammatory disorders, for gastroenterological disorders, Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation; diagnostic preparations for medical purposes; Material for diagnostic tests for medical use, namely, reagents, nucleotide sequences, enzymes, nucleotides for blood testing, reagents kit, chemical product, biomarking agents, blood derived samples, namely, plasma, serum, platelets, platelet free samples, red blood cells, and white cells; diagnostic agents for pharmaceutical and medical use, namely, for the treatment of metabolic disorders, liver diseases, cholestatic diseases, cancers, disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system, inflammatory disorders, for gastroenterological disorders, medical diagnostic reagents and assays for testing of body fluids, chemical diagnostic preparations for diagnostic tests for medical or clinical use for the preparation; radio-isotope markers for therapeutic or diagnostic useACTIVE—
010Surgical and medical apparatus and instruments, namely, apparatus for measuring NASH, liver fibrosis, cirrhosis, ASH, NAFLD and liver injury, noninvasive diagnostic apparatus and instruments for detecting liver injury; tools and instruments for medical diagnostics, namely, diagnostic apparatus and medical devices for diagnosis of liver diseases, blood analysis apparatus, DNA and RNA analysis apparatus, gene analyzer, medical devices for measuring the evaluation of liver diseases, and blood analysis toolsACTIVE—
044Medical health care consultancy services in the field of medical and/or health field metabolic disorders, liver diseases, cholestatic diseases, cancers, disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system, inflammatory disorders, for gastroenterological disorders,; Medical information; providing medical information to patients, medical professionals in the form of reports in the field of liver diseases, pharmaceutical-gene interactions; medical information services provided via the Internet; medical diagnostic testing servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Feb 22, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 7, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 7, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 1, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 29, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 10, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 10, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 10, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 10, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 10, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Sep 10, 2019CNSLSUSPENSION LETTER WRITTEN—
Aug 22, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 22, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 22, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jul 29, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 29, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Jul 29, 2019CNSLSUSPENSION LETTER WRITTEN—
Jul 18, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 18, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 16, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 25, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 25, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 25, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 25, 2019DOCKASSIGNED TO EXAMINER—
Dec 31, 2018AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Dec 31, 2018ALIEASSIGNED TO LIE—
Dec 21, 2018PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 11, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 24, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance